#shacey

[daydreambclievers]

@mollygetyourgun

regan loves her family. she really and truly does. but they can be a lot. and this party? definitely being a lot. she slips out the back door of the bar into the alley to smoke a cigarette and be alone for a few minutes. she must not be the only one who needs a breather, because she spots noah in the alley the second she looks up from lighting her cigarette and she smiles around it. she takes a drag and asks as she blows out the smoke, “guess we had the same idea, huh?”

[ndigitalhealth]

Novocuff Raises $26 Million in Series A Funding Round to Reduce Preterm Births Using a Novel Technology

Novocuff, Inc., a medical device technology company focused on improving pregnancy outcomes and minimizing the risk of preterm birth, has secured a $26 million series A funding round to fuel growth and support its pivotal clinical trials in the US.

The round was spearheaded by AXA Investment Managers via Global Healthcare Private Equity Strategy, supported by a significant investment from Laerdal Million Lives Fund.

The round also featured remarkable participation from existing and new investors, such as RH Capital, Laborie, March of Dimes, and Avestria Ventures.

Co-founded in 2021 by Amelia Degenkolb and Donald Lee, the company has received significant financial support since its launch with $2 million capital.

As part of the investment deal, Curt LaBelle, currently heading Healthcare Private Equity at AXA IM Alts, Vice President of Global Health Investing at AXA IM Alts Lilly deSouza Burr, and Becca Shmukler, from the Laerdal Million Lives Fund, joined the Board chaired by Shacey Petrovic.

Read more: https://nextdigitalhealth.com/funding-news/novocuff-raises-26-million-to-reduce-preterm-births-using-a-novel-technology/

fundingnews #FundingOpportunity #StartupFunding #StartupSuccess #HealthcareNews #MedicalTechnology #MedicalDevice #HealthcareFunding #nextdigitalhealth #Wi4 #vineetagrawal

[mollygetyourgun]

✔ (for the younger Lacey and Shane verse?)

✔  Young Shacey || meme || accepting.

Having three boys wasn’t easy when he had a partner to share it with. Having three boys and a daughter is nearly impossible now that it’s just him.

Before he met Maggie, Shane never felt the pull of paternal instincts. When Braden was born, those instincts only slowly started to come about. It took him years and three kids to finally be able to handle having sons.

And then Maggie got pregnant again.

And then she died and left him with a daughter.

And now he’s back at square one.

Single parents will tell you how hard it is to raise your children alone. They’ll go into details about all the things they had to learn to do on their own, how they had to make sacrifices, how there were things they’d miss and how they’d fail their kids a million times over.

Shane thought he was ready for that. He thought he could handle it.

How fucking naïve he’d been.

The first few years passed in a haze. Grief and guilt over the loss of Maggie gave way to exhaustion and loneliness. Raising their children was supposed to be something they did together, and now Shane was failing at doing it alone.

Who knew what would have become of his children if he hadn’t had his men to fall back on. His boys were picked up from school by gunmen. His daughter had had her diaper changed by felons. Dinners were made by the old ladies of convicts and thieves. Not exactly wholesome living.

Still, Shane couldn’t help but feel like something was coming. There was a change headed his way.

“Dylan Finnegan, hold on to your brother’s hand or so help me,” Shane said gruffly, Molly in one hand and Francis latched on to the other. His oldest looked up at him with the same exasperated look Shane assumed must be on his face. He’d like to believe that Dylan would grow out of this, but he knew better. Dylan was all Finnegan and they never grew out of anything.

When his boys finally linked hands, they set off down the block, making their way down the street to the bus stop. They walked past the club, the small pharmacy, and the abandoned pizzeria on their way.

“Daddy, look!” Molly said, tugging her father off their path to look into the window of the old shop and point. “It’s a cookie!”

Braden and Dylan paused and turned at their sister’s declaration. They let go of each other to hustle back and take their own look inside. A sign brightly declaring ‘Coming soon!’ with all sorts of baked confections.

“Someone’s moving in!” Braden said.

“So it seems,” Shane said with a nod. “Alright lads, you’ve had your look. We’re going to miss the bus if we don’t get goin’.” With that, he led his children away, looking back only to catch a flash of red hair moving around.

Everyday on their way to school after that, they stopped and looked in on the new bakery. Once or twice, a smiling young woman would wave at them and his children would wave back. Shane would smile bemusedly and offer a simple nod instead. If they only had more time, Shane was sure she’d even come out and say hello.

He could tell as the grand opening date came closer and closer, his children were getting more excited by the day. While Shane couldn’t even imagine going to a bakery as a child, he knew he wanted better for his brood. It didn’t take much convincing for him to agree to take them. Any resistance he might have felt left him as soon as he saw the hopeful look on Francis’ eyes.

So he agreed to take them as simple as that.

Somewhere in the back of his mind, he felt like something was clicking into place.

The bakery opened on a Saturday and it was certainly eventful. The neighborhood wasn’t the sort of place you imagined a sugar-sweet bakery full of bright colors and brighter frostings to be. Between Shane’s club and some of the other seedier businesses, Shane wasn’t sure how long this place would last. But maybe even convicts, thieves, and gunmen needed to buy sweets every now and then.

It certainly would help sell his doting single father image.

Braden and Dylan dashed ahead as soon as they could. Molly tugged impatiently, but it was Francis who looked up in awe. A wonderous smile spread across his face and Shane’s chest ached at the sight of it. His youngest son had so much of his mother in him, he wished she could see it.

He followed them, letting his kids explore the new space. Molly pressed her face against the glass case of cookies. Braden and Dylan were fighting about what cake flavor was better. Francis was just taking it all in. The crowded shop didn’t seem to bother any of them at all.

“Hi there! Welcome!” came a voice behind him that seemed just as sweet as the fudge Molly had moved on to.

He turned and paused. It was as if something was saying there you are. The young woman in front of him had an infectious smile, red hair, and bright green eyes. His heart skipped a beat in a way it hadn’t since Maggie and Shane knew whatever he had felt coming was here.

“Hello.”

Shane looked down and was surprised to see it was his youngest son who had spoken. Francis didn’t take to new people easily, but here he was beaming at the stranger.

She knelt to his level and offered his son the same blinding smile she’d given to him. “And just who might you be?” she asked.

“Frankie Finnegan,” he introduced himself. “I like your shop,” he added shyly.

“I like it, too!” Molly added, pushing herself in front to offer a gap-toothed smile of her own.

“Molly,” Shane warned. “Don’t shove.”

She looked up at him and Shane swore she rolled her eyes. His daughter was going to be trouble, he could already tell. He held out a hand to help the woman up. “I’m Shane Finnegan. I own the bar a few doors down,” he told her. “Molly and Francis are my youngest two. My oldest boys are the two over there fightin’ about frosting,” he told her pointing to the two troublesome boys at the counter trying to sneak a free taste.

She turned to see and laughed at the sight of them, sending warmth down Shane’s spine. “Well, hello to all of you!” she said when she turned back, looking down at his children before sending a look his way. “My name is Lacey and I am very excited you guys were able to come today. I’ve seen you on your way to school so I was hoping you’d come in.” She knelt down again. “Now I have a very important question for you two; what’s your favorite cookie?” she asked.

Molly, of course, shouted out her answer first but Francis took some time to think of his. When they both responded, Lacey nodded resolutely and stood up. “Come with me,” she said, leading them through the crowd with ease, grinning and greeting people along the way. She took both their hands and walked them around the counter. Shane watched with a small smile on his lips, enchanted by how quickly they took to her. “Now, as long as it’s okay with dad, how about some free samples of your favorite cookies?” she asked, looking up at Shane to make sure it was okay.

Molly and Francis spun to look at their dad, pleading with him to agree. At his nod, they cheered and turned back to her excitedly. Soon enough, Braden and Dylan made their way over and all but demanded the same treatment, which Lacey seemed thrilled to give.

When his kids were happily munching on their free cookie, Lacey made her way over to him. “And what about yours?” she asked. “Can’t leave you out,” she said before he had a chance to argue.

Shane hesitated for a moment. It wasn’t a commitment. It wasn’t even a promise of something. Just a cookie. Still, he couldn’t help but feel like it could lead to so much more than that. He grinned at her, deciding that whatever came his way would be worth it. “I don’t think I have a favorite. What’s yours? Maybe it’ll end up being mine, too.”

Lacey seemed to pause for a moment before another smile blossomed on her pretty face. “Well, we’ll just have to find your favorite, won’t we?”

Shane didn’t think at the time that the comment would lead to something, but any time he brought the kids in, Lacey made him try a new cookie. It seemed like finding his favorite was now a quest for her. After each new sample, which she insisted was free and he insisted on paying for, she asked him what he thought. Her excited smiles always made him tell her the same thing. “Best one yet, but I’m not sure if it’s a favorite.”

She would laugh and tell him they’d just need to keep trying. Shane’s heart would skip a beat again and he’d pretend it wouldn’t. It wouldn’t do for a man in his line of work to develop feelings for someone as innocent as Lacey. He’d done that before and it had ended in tragedy.

Still, like an itch, he kept going back. Most often with his children and occasionally without them. Each time, Lacey’s face would light up at the sight of him. Through his visits, they’d started to get to know each other. He asked her how she settled in this neighborhood while she asked him about his kids and their likes and dislikes. Simple questions led to deeper conversations about failures and past loves. He told her bits and pieces about Maggie. She opened up to him about her family.

This nothing was quickly becoming something, and he didn’t know what to do with it.

One night, he dreamed of Maggie. Not how she was, but how she could have looked now. A few years more weather-worn with streaks of grey they probably would have attributed to Braden and Dylan. She had more laugh lines and Shane felt lighter seeing her this way.

What are you waiting for? Dream Maggie had asked him. You can’t be afraid of opening your heart up to someone, Shane Finnegan. All my hard work would be for nothing if you did that.

Shane tried to ask her what she meant by that, but his late wife just laughed.

You get to love again, Shane. In fact, I insist on it. You get to fall in love and be happy. She’ll be good for you. She’ll be good for all of you, Maggie said to him, taking his hands in hers.

When he didn’t say anything, Dream Maggie leaned in and pressed a kiss to his forehead. Lacey is your second chance, my love. Don’t let her slip away.

He shot out of bed after that, scrubbing his hands down his face. He swore he could still a trace of Maggie’s kiss.

The next morning, after dropping the kids off at the bus, Shane went right to the bakery. Lacey was in the back and called out as soon as she heard the bell over the door ring. “I’ll be right out!”

Shane pressed his hands against the counter as he waited, nervously tapping his fingers. He couldn’t remember the last time he had felt this way.

When she saw him, there was that smile again. “Shane! What are you doin’ here?” she asked.

“I was wonderin’ if you’d like to get some coffee sometime?” he asked without delay and getting right to the point.

Lacey arched an eyebrow at that, though a smile played at the corners of her lips. “Depends,” she started with a small smirk. “You asking me out on a date, Finnegan?” she asked teasingly.

Shane smiled softly. “That’s exactly what I’m doin’, Lace. You acceptin’?”

“That’s exactly what I’m doing,” she echoed.

He grinned wider than he had in ages. He could picture this, them, together and it felt right. Maybe he didn’t have to do this alone after all.

Somewhere, in the back of his head, Shane imagined Maggie’s approval. And that felt right, too.

[heartfullofxfright]

@mollygetyourgun sent  “i’m not a particularly good person.  but sometimes i wish someone would think i am.” - Shacey

“i think you are,” she tells him, small smile on her face as she rests her hand on his forearm across the case. “you’re good, maybe not all the time, but you’re good to me, you’re good to the kids, you’re better than you realize.” she gives his arm a gentle squeeze. she turns to grab the rag so she can finish cleaning the case for the night. “what brought all this on?” 

[image-transcribing-bot]

shacey. you server trow our voice Ano make A scoomy soup uike a swam TIME FOR A L vENTRILOQUE *Train Noises LISTEN THAT SH le] as J [ AND NEX IY SUPER SHAGGY IMITAT OF REDBEARD

I am an image transcribing bot which uses Tesseract OCR to translate images to text. I'm far from perfect but I try my best! You're a good Human®! ^_^ | PayPal | Patreon

In my Scooby Doo Lore Post the comment made about the gang ignoring Scooby’s ability to talk garnered some important attention:

Now that’s a super valid concern but it’s also canon that in the original series Shaggy is a highly talented Ventriloquist and Impressionist so it’s entirely possible that Scooby can’t actually talk at all and the whole gang knows it’s just Shaggy voicing him

[randybenedict]

Insulet president & CEO Shacey Petrovic to participate in keynote interview at DeviceTalks Boston 2019

[Press Release] – WTWH Media and MassDevice.com announced today that Shacey Petrovic, president and CEO of Insulet (NSDQ:PODD), will be a featured keynote speaker at DeviceTalks Boston 2019.

DeviceTalks Boston, which takes place on June 5-6, 2019, at the Seaport World Trade Center, brings together engineering, product development and commercialization professionals to share the challenges and best practices of getting medical devices to the market.

“Over the last eight years, DeviceTalks Boston has cultivated a network of nearly 1,000 medical technology professionals by offering world-class keynote speakers. This year, we are thrilled to feature a keynote interview with Shacey Petrovic, President and CEO of Insulet,” said DeviceTalks content manager Sarah Faulkner.

“Shacey has worked at Insulet since 2015, starting as the Mass.-based company’s chief commercial officer and working her way up to the corner office. We are so excited that she will join us at DeviceTalks Boston to share her story and give attendees a glimpse into the future of diabetes management,” Faulkner added.

Recruiting from the best of Boston’s medtech ecosystem, DeviceTalks Boston highlights speakers who will explore how to build better devices and better companies. To register, visit www.boston.devicetalks.com.

The post Insulet president & CEO Shacey Petrovic to participate in keynote interview at DeviceTalks Boston 2019 appeared first on MassDevice.

from MassDevice http://bit.ly/2SrN3mG

[socialglycemic]

I cannot wait for Insulet’s “loop” system...

I cannot wait for Insulet’s “loop” system…

I cannot wait for Insulet’s “loop” system (Horizon) to come out. The algorithm is in the pods so the pods will talk to the Dexcom directly without needing the smart device to communicate! So excited!!! Check out @juiceboxpodcast to hear Scott’s interview with Shacey Petrovic about all that’s in the works with Insulet / Omnipod. The new PDM (Dash) should hopefully be out in the first half of 2018.…

[healthcarebiz]

Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR(R)NEXT ONE BGMS and Omnipod Dash(TM) PDM

BASEL, Switzerland, June 8, 2017 /PRNewswire/ -- Ascensia Diabetes Care today announced it has entered into a strategic alliance by signing a development agreement with Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its Omnipod® Insulin Management System (the Omnipod System). Under the terms of this agreement, the Ascensia CONTOUR®NEXT ONE blood glucose monitoring system (BGMS) will connect to Insulet's next-generation Omnipod System (the Omnipod Dash™ System), which is currently in development. Seamlessly connecting the CONTOUR®NEXT ONE BGMS and the Omnipod Dash™ System will provide people living with diabetes with an innovative continuous insulin delivery system to manage their diabetes, powered by remarkably accurate blood glucose readings.

The CONTOUR®NEXT ONE BGMS will pair, via Bluetooth Low Energy (BLE), with the Omnipod Dash™ Personal Diabetes Manager (Omnipod Dash™ PDM) to automatically transmit a person's blood glucose readings directly into the system. These readings will be used by the Omnipod Dash™ PDM to calculate insulin dosing and support highly accurate delivery of insulin for people living with diabetes. Under the terms of this worldwide non-exclusive agreement, Insulet will develop and seek marketing clearance for the Omnipod Dash™ PDM, with collaboration from Ascensia Diabetes Care who will provide the CONTOUR®NEXT ONE meter and CONTOUR®NEXT test strips.

"We are delighted to enter into this agreement that brings together these innovative technologies from both companies," said Michael Kloss, CEO, Ascensia Diabetes Care. "The integration of our BGM system with Insulet's tubeless insulin pump system has significant potential to help people take control of their lives and their diabetes. We are pleased that our highly accurate system has been chosen to provide the critical blood glucose data that will be used by the Omnipod Dash™ PDM to calculate insulin dosing for patients."

"We are thrilled to partner with Ascensia as part of our development efforts on our next-generation Omnipod Dash platform, which will allow Insulet to maintain its competitive edge with truly innovative and differentiated products," said Shacey Petrovic, President and Chief Operating Officer.

The CONTOUR®NEXT ONE BGMS received 510(k) clearance from the FDA in November 2016 and has been shown to meet the stricter accuracy requirements of the FDA Over-the-Counter BGMS Guidance that was recently issued in 2016. In a clinical study, 95% of blood glucose results obtained with the CONTOUR®NEXT ONE BGMS were within 8.4 mg/dL (0.5 mmol/L) or 8.4% of the reference result for subject fingertip tests.[1]

Michael added, "This alliance is the next step in our goal of providing integrated solutions for people living with diabetes. We believe that integrated diabetes management is the future and are happy to work with partners that will help us to achieve this goal together. One aspect of this is pump therapy, where we have established ourselves as the partner of choice for blood glucose monitoring in the pump sector. We are excited that Insulet recognizes the value the CONTOUR®NEXT ONE BGMS can bring to users of Omnipod's product platform."

Notes for Editors 

About Ascensia Diabetes Care 

Ascensia Diabetes Care is a global specialist diabetes care company, dedicated to helping people living with diabetes. Our mission is to empower people living with diabetes through innovative solutions that simplify and improve their lives. We use our innovation and specialist expertise in diabetes to develop high quality solutions and tools that make a positive, daily difference for people with diabetes.

Home to the world renowned CONTOUR® portfolio of blood glucose monitoring systems, our products combine advanced technology with user-friendly functionality that help people with diabetes to manage their condition. We are committed to continued research, innovation and development of new products and solutions. As a trusted partner in the diabetes community, we collaborate closely with healthcare professionals and other partners to ensure our products meet the highest standards of accuracy, precision and reliability, and that we conduct our business compliantly and with integrity.

Ascensia Diabetes Care was established in 2016 through the sale of Bayer Diabetes Care to Panasonic Healthcare Holdings Co., Ltd. Ascensia Diabetes Care products are sold in more than 125 countries. Ascensia Diabetes Care has around 1,700 employees and operations in 33 countries.

For further information, please visit the Ascensia Diabetes Care website at: http://www.ascensia.com.

About Insulet Corporation 

Insulet Corporation (NASDAQ: PODD) is an innovative medical device company dedicated to making the lives of people with diabetes easier. Through its Omnipod Insulin Management System, Insulet seeks to expand the use of insulin pump therapy among people with insulin-dependent diabetes. The Omnipod is a revolutionary and easy-to-use tubeless insulin pump that provides up to three days of non-stop insulin delivery, without the need to see or handle a needle.  Insulet's Delivery Systems business also partners with global pharmaceutical and biotechnology companies to adapt the Omnipod technology platform for the delivery of subcutaneous drugs across multiple therapeutic areas. Founded in 2000, Insulet Corporation is based in Billerica, Massachusetts. For more information, please visit: http://ift.tt/1nJvtB0.

© 2017 Ascensia Diabetes Care. Ascensia and Contour are trademarks and/or registered trademarks of Ascensia Diabetes Care. All other trademarks are the property of their respective owners. The use of third party trademarks does not constitute an endorsement or imply a relationship or other affiliation.

References

1. Christiansen et al. Poster presented at the 15th Annual Meeting of the Diabetes Technology Society, October 22-24, 2015, Bethesda, Maryland.

For further information, please contact: Joseph Delahunty Ascensia Diabetes Care joseph.delahunty@ascensia.com Tel: +41-61-560-8760

Read this news on PR Newswire Asia website: Ascensia Diabetes Care Announces Strategic Alliance with Insulet Corporation to Connect CONTOUR(R)NEXT ONE BGMS and Omnipod Dash(TM) PDM

[type2diabetestreatments-blog]

Data show positive results for Insulet's hybrid closed-loop system

New Post has been published on http://type2diabetestreatment.net/diabetes-research/data-show-positive-results-for-insulets-hybrid-closed-loop-system/

Data show positive results for Insulet's hybrid closed-loop system

Insulet (NSDQ:PODD) touted data today from the 1st feasibility study of its Omnipod Horizon hybrid closed-loop system in patients with Type 1 diabetes. Data from the study showed that the Omnipod automated glucose control algorithm performed well, with minimal hypoglycemia, and that it was safe.

The Billerica, Mass.-based company enrolled 24 patients with Type 1 diabetes in the 36-hour study. The feasibility trial used a modified version of Insulet’s Omnipod, a Dexcom continuous glucose monitor and Insulet’s personalized model predictive control algorithm..

Use of the system was associated with significantly less time spent in hypoglycemic blood glucose range, Insulet reported, compared to ranges prior to the study. The study showed that patients hit the target blood glucose control range 69% of the time over the course of the 36 hours and maintained target blood glucose control 90% of the time overnight.

“These very positive results, particularly in the overnight period, demonstrate the potential for the Omnipod Horizon System to improve clinical outcomes in patients with Type 1 diabetes,” principal investigator Dr. Bruce Buckingham said in prepared remarks. “This is a safe system providing significant reductions in hypoglycemia both during the day and night, and the system made significant improvements in overnight glucose control, decreasing glucose variability and bringing fasting glucose values into range. These are very positive early findings and I think I speak for the entire team when I say I am excited to see how the Horizon system continues to perform in future clinical studies.”

“We are incredibly excited by the early results of this trial, which demonstrated excellent glucose control and tremendous promise to make a significant impact for patients,” president & chief operating officer Shacey Petrovic added. “Omnipod allows our users to feel more confident, and to experience improved quality of life and outcomes, and we are thrilled our Omnipod Horizon System is already demonstrating the ability to continue to make a significant impact on improving the lives of people with diabetes.”

Earlier this week, Insulet said it acquired a manufacturing facility in Acton, Mass. that will allow it to more efficiently manufacture the OmniPod system compared to the company’s manufacturing lines at its contract manufacturer in China.

The company anticipates the new facility will add hundreds of jobs in Massachusetts over the next 5 years, Insulet said, and expects to begin production in 2019.

Type 2 Diabetes Treatment Type 2 Diabetes Diet Diabetes Destroyer Reviews Original Article

[shawn--dixon]

Shawn: Just admit it Lace, it's not like this is news to me anymore. I just want to hear the words come out of your mouth.

Lacey: Fuck off. It's never gonna happen.

Shawn: Wanna bet?

[graceof1x1]

ROLEPLAY MEME

2/5 OTPs: Shawn Dixon and Lacey Joel aka Shacey

[ns-confessions]

This one's for you Stacey. I We hope you say yes ;)

Source: Shane Valentine

[joannatago]

Cutest thing evuuurrr!!! 🐾 #Shacey

[randybenedict]

Insulet taps former Medtronic finance exec McMillan as CFO | Personnel Moves – January 8, 2019

Insulet (NSDQ:PODD) said yesterday that it tapped former Medtronic minimally invasive therapies CFO and finance VP Wayde McMillan as its new chief financial officer, replacing Michael Levitz.

The Acton, Mass.-based diabetes-focused medtech company said that McMillan will join the company in February and that Levitz will continue as an advisor for a period following the succession to ensure a smooth transition. McMillan will officially take the role of CFO on March 1.

Prior to joining Insulet, McMillan held executive roles in finance at Medtronic, having come to the company during its acquisition of Covidien in 2015. After the acquisition, McMillan helped reorganize the new acquisition into the Medtronic Group structure, the company said.

“We are excited to welcome a leader of Wayde’s caliber to Insulet as the company transitions to profitability, expands internationally, and enters its next phase of rapid growth. Wayde has significant expertise scaling large organizations and a thorough understanding of the strategies we are pursuing globally to accelerate growth and build on our strong foundation. We look forward to benefitting from Wayde’s experience as we continue to position the company for long-term success and solidify our leadership in the global management of diabetes. On behalf of the board of directors and the entire company, I want to thank Mike Levitz for his numerous contributions, as well as his support during this transition period. Over the last four years, Mike has helped develop and execute our strategic imperatives, strengthen our infrastructure and capabilities in support of future growth, and generate exceptional value for shareholders. We wish Mike all the best in his future endeavors,” prez & CEO Shacey Petrovic said in a prepared statement.

“I am honored to join the team at Insulet, a company with a strong mission dedicated to improving the lives of people impacted by diabetes. I look forward to working alongside the Insulet leadership team and contributing to the company’s initiatives to drive growth, profitability and value creation for shareholders,” McMillan said in a press release.

 Senseonics appoints Isaacson as CFO

Senseonics (NYSE:SENS) said yesterday that it named Jon Isaacson as its new chief financial officer, replacing R. Don Elsey.

Elsey will remain on with the Germanton, Md.-based company in an advisory role to support the transition and to assist in preparation of the company’s annual report filings for the previous fiscal year. Elsey is slated to stay on until his planned retirement date of February 28, or a later date if another agreement is made.

Prior to joining Senseonics, Isaacson acted as CFO of Edelman Financial Services from November 2017 to December 2018, and as managing director of private equity firm American Capital, the company said.

Read more

 Livongo names Shapiro as CFO

Livongo said last week that it appointed board member and audit committee chair Lee Shapiro as its new chief financial officer, effective on February 1.

Shapiro currently serves as a member of the board and audit committee for Medidata Solutions and as the audit committee chair of Tivity Health, Mountain View, Calif.-based Livongo said. He also served at Allscripts Healthcare Solutions as president from 2001 to 2012, the company added.

“I couldn’t be more excited about working with Lee. His intimate knowledge of Livongo, his close working relationships with the leadership team, and his connections across the industry, including virtually every analyst in the healthcare and technology space, will allow us to rapidly accelerate our business and better serve our members and clients,” CEO Zane Burke said in a press release.

“Lee’s experience in scaling companies is a perfect fit for Livongo as the company moves to the next level. I speak for the entire team in sharing my enthusiasm in gaining Lee’s experience in building great companies for Livongo,” exec chair Glen Tullman said in prepared remarks.

“I have been impressed with what the Livongo team has accomplished in such a short time. As the company continues its rapid acceleration, my hope is to contribute in both financial and strategic ways to serve Livongo’s mission of empowering more people with chronic conditions to live better and healthier lives,” Shapiro said in a prepared statement.

Read more

 Reva Medical lifts Elkolli to CFO

Reva Medical (ASX:RVA) said last week that it promoted Leigh Elkolli to the office of chief financial officer and corporate secretary, replacing Brandi Roberts who resigned, effective January 4.

Elkolli joined San Diego-based Reva Medical in August 2017 as finance senior director and corporate controller, the company said. Elkolli previously worked with privately held biotech company Avidity Biosciences, serving as finance director.

Read more

 Wright Medical shuffles the exec roster

Wright Medical (NSDQ:WMGI) yesterday announced a number of internal organizational changes, including lifting current prez Kevin Cordell to the position of chief global commercial officer and exec VP and promoting senior VP and CFO Lance Berry to the newly created position of chief financial and operations officer and exec VP.

Cordell joined Wright in 2014, and has helped integrate the U.S. commercial teams of Tornier after the companies merged, Wright said. In conjunction with his promotion, current int’l prez Peter Cooke will assume the role of president of emerging markets, Australia and Japan and current upper extremities marketing VP Steve Wallace was promoted to int’l prez, the company said.

In his new role, Amsterdam-based Wright Medical said that Berry will be responsible for global finance and accounting, operations, quality, regulatory, information technology, strategy and corporate development.

“Wright Medical is quickly becoming a $1 billion high-growth medtech company that is built to win in the fast-growing Extremities and Biologics markets.  As we continue to grow and progress, there is a need to better align our team to support long-term revenue growth, profitability and day-to-day execution.  At the same time, we must stay strategically focused to maintain our technology differentiation and leadership positions.  It is with these goals in mind that I am creating two new executive vice president positions, reporting to me, to advance our global commercial focus and to further transform our global business processes. With significant opportunities ahead, these organizational changes will allow for further alignment of our cross functional organizations with a stronger and sharper focus on long-term growth and profitability, including a greater emphasis on the emerging market opportunity.  I am looking forward to working with Kevin and Lance in their new leadership roles and am confident that these appointments, along with our other organizational changes, will further bolster our ability to capitalize on the growth opportunities in front of us and accelerate our market performance,” prez & CEO Robert Palmisano said in a prepared statement.

Read more

Flow control co. Circo taps Smith & Nephew ex-US CFO Chahine as SVP, CFO

Pressao Medical taps Pak as new CEO

TAE Life Sciences adds Hill as COO

Quanta Dialysis Tech names Komenda as chief med officer

Bonesupport appoints Vikner as global marketing & communications exec VP

Cerus Corp taps Moore as manufacturing operations and supply chain senior VP

AxoGen names Crisman as US sales VP

GI Dynamics appoints Linhares as clinical & regulatory affairs VP

The post Insulet taps former Medtronic finance exec McMillan as CFO | Personnel Moves – January 8, 2019 appeared first on MassDevice.

from MassDevice http://bit.ly/2FfE9BS